Chlorhexidine gluconate or polyhexamethylene biguanide disc dressing to reduce the incidence of central-line-associated bloodstream infection: A feasibility randomized controlled trial (the CLABSI trial).

. (2017). Chlorhexidine gluconate or polyhexamethylene biguanide disc dressing to reduce the incidence of central-line-associated bloodstream infection: A feasibility randomized controlled trial (the CLABSI trial).. Journal of Hospital Infection, 96(3), 223-228. SID. https://sid.ir/paper/783414/en

. Chlorhexidine gluconate or polyhexamethylene biguanide disc dressing to reduce the incidence of central-line-associated bloodstream infection: A feasibility randomized controlled trial (the CLABSI trial).. Journal of Hospital Infection[Internet]. 2017;96(3):223-228. Available from: https://sid.ir/paper/783414/en

, “Chlorhexidine gluconate or polyhexamethylene biguanide disc dressing to reduce the incidence of central-line-associated bloodstream infection: A feasibility randomized controlled trial (the CLABSI trial).,” Journal of Hospital Infection, vol. 96, no. 3, pp. 223–228, 2017, [Online]. Available: https://sid.ir/paper/783414/en